ArcherDX

ArcherDX Focuses on Tackling Bottleneck Issues in Next-Generation Sequencing Detection of Tumor Mutation Genes. Its Proprietary Robust and Reliable Targeted Gene Sequencing Platform, Utilizing Exclusive Chemical Reagents, Generates Highly Enriched Sequencing Libraries to Accurately Detect Gene Fusions, Point Mutations, Copy Number Variations (CNV), and RNA Abundance from Solid Tumors, Hematologic Cancers, Sarcomas, and Liquid Biopsy Samples.